Transport of phytanic acid on lipoproteins in Refsum disease

Journal of Inherited Metabolic Disease

Volumn 22, Issue 1, 1999, Pages 29-36

  Wierzbicki, A S ^a   Sankaralingam, A ^a   Lumb, P J ^a   Hardman, T C ^b   Sidey, M C ^c   Gibberd, F B ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTANIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ARTICLE; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FATTY ACID TRANSPORT; HUMAN; NERVOUS TISSUE; REFSUM DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

BIOLOGICAL TRANSPORT; HUMANS; LIPOPROTEINS; PHYTANIC ACID; REFSUM DISEASE;

EID: 0032990546     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005486913371     Document Type: Article

References (23)

1. 14C-labelled phytol and phytanic acid by the intestine of the rat studied with thoracic duct cannulation. Biochim Biophys Acta 132: 277-281.
2. Britton TC, Gibberd FB, Clemens ME, Billimoria JD, Sidey MC (1989) The significance of plasma phytanic acid levels in adults. J Neurol Neurosurg Psychiatry 52: 891-894.
3. Brown PJ, Mei G, Gibberd FB, et al (1993) Diet and Refsum's disease: The determination of phytanic acid and phytol in certain foods and the application of this knowledge to the convenience foods for patients with Refsum's disease. J Hum Nutr Diet 6: 295-305.
4. 2, cofactor requirements, subcellular organisation and formation of 2-hydroxy-3-methylacyl-CoA intermediate. Eur J Biochem 240: 674-683.
5. Ellingboe J, Steinberg D (1972) Differential susceptibility of phytanyl and palmityl ester bonds to enzymatic hydrolysis. Biochim Biophys Acta 270: 92-94.
6. Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228.
7. Gibberd FB, Billimoria JD, Goldman JM et al (1985) Heredopathia atactica polyneuritiformis : Refsum's disease. Acta Neurol Scand 72: 1-17.
8. Goldman JM, Clemens ME, Gibberd FB, Billimoria JD (1985) Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease). Br Med J 290: 1109-1110.
9. Harari D, Gibberd FB, Dick JR, Sidey MU (1991) Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis). J Neurol Neurosurg Psychiatry 54: 614-617.
10. Jansen GA, Wanders RJ, Wtakins PA, Mihalik SJ (1997a) Phytanoyl-coenzyme A hydroxylase deficiency - the enzyme defect in Refsum's disease. N Engl J Med 337: 133-134.
11. Jansen GA, Ofman R, Ferdinandusse S, et al (1997b) Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nature Genetics 17: 190-193.
12. Laudat P, Wolf L-M (1969) Repartition des esters phytaniques parmi les triglycerides plasmatiques de cinq patients atteints de maladie de Refsum: etude par chromatographie en couche mince. Biochim Biophys Acta 176: 245-247.
13. Laurell S (1968) The action of lipoprotein lipase on glycerly triphytanate. Biochim Biophys Acta 152: 80-82.
14. Laurell S (1978) Separation and characterisation of phytanic acid containing plasma triglycerides from the serum of a patient with Refsum's disease. Biochim Biophys Acta 152: 75-79.
15. Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ (1997) Identification of PAHX, a Refsum disease gene. Nature Genetics 17: 185-189.
16. Molzer B, Bernheimer H, Barlolin GS, Hofinger E, Lenz H (1979) Di-, mono- and non-phytanoyl triglycerides in the serum: a sensitive parameter of the phytanic acid accumulation in Refsum's disease. Clin Chim Acta 91: 133-137.
17. Moser HW, Moser AB (1991) Measurement of phytanic acid levels. In Hommes FA, ed. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. Philadelphia: Wiley-Liss, 193-203.
18. Steinberg D (1995) Refsum disease. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 2351-2369.
19. Verhoeven NM, Schor DS, ten Brink HJ, Wanders RJ, Jacobs C (1997a) Resolution of the phytanic acid alpha-oxidation pathway: identification of pristanal as the product of the decarboxylation of 2-hydroxy-phytanoyl-CoA. Biochem Biophys Res Commun 237: 33-36.
20. Verhoeven NM, Schor DS, Previs SF, Brunengraber H, Jacobs C (1997b) Stable isotope studies of phytanic acid alpha-oxidation: in vivo production of formic acid. Eur J Paediatr 156 (Supplement 1): S83-87.
21. Verhoeven NM, Schor DS, Roe CR, Wanders RJ, Jacobs C (1997c) Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts. Biochim Biophys Acta 1361: 281-286.
22. Verhoeven NM, Wanders RJ, Schor DS, Jansen GA, Jacobs C (1997d) Phytanic acid alpha oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver. J Lipid Res 38: 2062-2070.
23. Yao JK, Dyck PJ (1987) Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease. Lipids 22: 69-75.